Serial Number | 97097829 |
Word Mark | OXEIA |
Filing Date | Thursday, October 28, 2021 |
Status | 654 - REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED |
Status Date | Friday, February 9, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | NOT AVAILABLE |
Description of Mark | The mark consists of a silhouette of a person's head with the top half consisting of non-connecting triangles. |
Goods and Services | Pharmaceutical preparations for use in neurotrauma and neurology; pharmaceutical preparations for treating concussions, brain injuries and dysfunctions, neurodegeneration, and neurologic diseases, conditions, and disorders; therapeutic preparations for use in neurotrauma and neurology for stabilizing brain metabolism and energy |
Goods and Services | Pharmaceutical research and development; providing medical and scientific research information in the fields of concussions, brain injury, neurodegeneration, and neurology |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, November 10, 2021 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, November 10, 2021 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Oxeia Biopharmaceuticals, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Boston, MA 02115 |
Event Date | Event Description |
Friday, February 9, 2024 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
Friday, February 9, 2024 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
Saturday, August 12, 2023 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
Sunday, February 12, 2023 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
Sunday, February 12, 2023 | LETTER OF SUSPENSION E-MAILED |
Sunday, February 12, 2023 | SUSPENSION LETTER WRITTEN |
Thursday, February 9, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Thursday, February 9, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Thursday, February 9, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Tuesday, August 9, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Tuesday, August 9, 2022 | NON-FINAL ACTION E-MAILED |
Tuesday, August 9, 2022 | NON-FINAL ACTION WRITTEN |
Saturday, August 6, 2022 | ASSIGNED TO EXAMINER |
Thursday, November 11, 2021 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
Wednesday, November 10, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Monday, November 1, 2021 | NEW APPLICATION ENTERED |